Kiniksa Pharmaceuticals International, plc (KNSA)

SEC filing

Kiniksa Pharmaceuticals International, plc

KNSA · CIK 1730430

4 · Nov 14, 2025 · Ragosa Mark sold 19.90K shares at $40.94/share ($814.7K); exercised options for 19.90K shares

Ragosa Mark sold 19.90K shares at $40.94/share ($814.7K); exercised options for 19.90K shares

xslF345X05/form4-11142025_091151.xml

xslF345X05/form4-11142025_091151.xmlSEC.gov

Graphics and non-inline formats (not embedded below).